Another key potential reason for this difference is that our method cannot detect expansion of CGG repeats in the causal gene of fragile X syndrome, FMR1. Regardless, our method can still facilitate the evaluation of the proband and family for expected clinical features, which is especially important for the differential diagnosis of ASD cases. The gene discussed is FMR1; the disease is fragile X syndrome.